Zuranolone: First Oral Medication FDA Approved for Postpartum Depression
On Aug 4, 2023: Biogen announced the FDA approval of ZURZUVAEâ„¢ (Zuranolone) for Women with Postpartum Depression. This is the first oral medication approved for this indication. This approval is based on the results of two phase 3 clinical trials where the improvement in depression was seen as early as Day 3 with sustained effect to Day 45.
Postpartum depression is a common mental health condition that affects new mothers, potentially leading to profound consequences for both mother and child. Recognizing the significance of this condition and understanding its treatment needs are crucial steps in supporting mothers on their path to recovery.
Psychiatry Education Forum Academy has summarized this newly approved medication in clinically relevant discussions.Â
WATCH PART OF THIS DISCUSSION ON:
HOW TO DOSE ZURANOLONE?
[FOR PEFA MEMBERS]
ZURANOLONE FOR POSTPARTUM DEPRESSION
Psychiatry Education Forum Academy have summarized this medication in the following 10 sections:
- Indication
- Mechanism of Action?
- How to Dose?
- When to Use the Low Dose?
- When to Avoid & Discontinue?
- How to Manage Missed Doses?
- Drug Interactions to Consider?
- Most Common Adverse Reactions?
- Use with Breastfeeding?
- Clinical Trial Data.
INTERESTED IN LEARNING MORE?
JOIN PSYCHIATRY EDUCATION FORUM ACADEMY MEMBERSHIP
This is a closed membership for medical professionals only.
- 30+ Courses/Sections: Each chapter within these sections is of direct clinical relevance for your daily practice.Â
- Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice.
- Coffee Club: contain short discussions with clinical experts in the field of psychiatry.
- Clinical Case Discussions: Discussions of clinical cases from our daily clinical practice.Â
- Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases.
- Essentials of Inpatient Psychiatry Book: All chapters from this book are included in the academy sections.Â
- Goal: is to have all important clinically relevant topics in one place for ease of access.
